GENEMEDICS APP

GENEMEDICS NUTRITION

Delta Sleep-Inducing Peptide

Author: Dr. George Shanlikian, M.D.  |   Last Updated: November 26th, 2024

Share This Page

Book a Free Consultation

Overall Health Benefits of Delta Sleep-Inducing Peptide

Sleep-Inducing Peptide offers numerous benefits, including the improvement of sleep quality and the enhancement of sleep patterns, potentially reducing the time it takes to fall asleep and increasing the duration of deep sleep stages. It also holds promise for mitigating symptoms of stress and anxiety, contributing to overall mental and physical well-being.

  • Improves Sleep Quality [1-15]
  • Reduces Chronic Pain [16-18]
  • Fights Stress [19-26]
  • Boosts Brain Power [27-34]
  • Treats Depression [16, 35-39]
  • Lowers the Risk of Heart Disease [40-43]
  • Lowers Blood Pressure [44-45]
  • Prevents Cancer and Reduces the Side Effects of Chemotherapy [46-47]
  • Treats Symptoms of Diabetes [48-50]
  • Provides Support for Alcohol and Drug Withdrawal [51-54]

Key Takeaways

  • Function: DSIP is a naturally occurring peptide that plays a role in promoting sleep. It is believed to contribute to the regulation of sleep-wake cycles and may help induce delta-wave sleep, which is deep and restorative.
  • Research: While DSIP’s exact mechanism of action is not fully understood, research suggests it interacts with the central nervous system, particularly in the hypothalamus, to influence sleep patterns. Studies have shown its potential in enhancing sleep quality and duration.
  • Medical Potential: DSIP has drawn interest for its potential therapeutic applications in treating sleep disorders such as insomnia and disruptions in circadian rhythm. Research continues to explore its efficacy and safety in clinical settings.
  • Safety and Caution: Due to limited conclusive research, caution is advised in using DSIP, especially for individuals with underlying hormonal or neurological disorders. More comprehensive studies are needed to establish clear guidelines for its safe use.
  • Future Directions: Ongoing research aims to elucidate DSIP’s broader effects on sleep regulation and its potential as a pharmaceutical agent. Further studies may lead to advancements in understanding its precise mechanisms and therapeutic applications.

What is Delta Sleep-Inducing Peptide (DSIP)?

Delta sleep-inducing peptide, also known as DSIP, was first detected in rabbits’ brains back in 1977. As its name suggests, DSIP is used to promote sleep and help people with different types of sleeping problems. Numerous studies have proven its beneficial effects on sleep quality without any adverse effects. As a potent antioxidant, DSIP may help support the central nervous and endocrine systems by reducing the levels of damaging free radicals.

How Delta Sleep-Inducing Peptide Works

Delta sleep-inducing peptide works by targeting multiple sites in the brain including the brainstem to induce sleep. It interacts with the hormones serotonin and melatonin which are involved in the induction of sleep and regulation of sleep patterns.

Chemical Structure of Delta Sleep-Inducing Peptide

Research on Delta Sleep-Inducing Peptide

A. Improves Sleep Quality

Front view young woman enjoying music

A number of studies support the beneficial effects of DSIP on sleep quality and quantity:

  1. A study showed that DSIP can stimulate sleep in disturbed human sleep patterns. [1]
  2. In patients with insomnia, DSIP injection resulted in longer sleep duration with reduced interruptions. [2-6]
  3. These takeaways provide a concise overview of DSIP’s current understanding and potential implications in sleep medicine and research. In cats, a single injection of DSIP effectively shortened sleep latency and significantly increased the total sleep duration. [7]
  4. Studies showed that DSIP was effective in inducing delta sleep (deep stage of sleep) in rabbits, rats, mice, cats, and humans. [8-11]
  5. A study showed that high-dose administration of DSIP was associated with improvements in symptoms of insomnia. [12]
  6. In healthy individuals, DSIP was effective in inducing sleep without any side effects. [13]
  7. Studies described DSIP as a sleep-promoting peptide rather than a sedative. [14-15]

B. Reduces Chronic Pain

Evidence suggests that DSIP has pain-relieving properties:

  1. In patients with chronic, pronounced pain episodes, the intravenous administration of DSIP lowered the pain levels of the subjects. [16]
  2. In mice and rats that had undergone the tail-pinch and hot-plate tests, pretreatment with DSIP produced pain-relieving effects. [17]
  3. The administration of DSIP reduced pain levels in patients with headaches and other pain syndromes. [18]

C. Fights Stress

DSIP has also been shown to help fight stress:

  1. In animal models of stress, DSIP administration reduced behaviors associated with stress. [19-20]
  2. In rats, DSIP injections significantly increased acute emotional stress resistance. [21]In rats
  3. treated with chlorpromazine-morphine-pentobarbital, DSIP administration significantly reduced the levels of the stress hormone cortisol. [22-23
  4. In rats, higher levels of DSIP were associated with more resistance to emotional stress. [24-26]

D. Boosts Brain Power

DSIP is not only vital for sleep but also for brain health:

  1. In rats, DSIP injections significantly increased their resistance against acute emotional stress. [27]
  2. A study showed that the stress-protective effects of DSIP can be attributed to its antioxidant properties. [28]
  3. In rats with cerebral ischemia (low blood supply in the brain), DSIP administration resulted in increased blood supply and higher survival rates. [29]
  4. In adult male rats, DSIP administration greatly reduced the occurrence, duration, and severity of seizures, suggesting that it is a suitable antiepileptic drug. [30-31]
  5. In animals with cerebral ischemia, DSIP reduced the severity and lethality of the condition. [32]
  6. In rats, the improved sleep quality from DSIP injection further resulted in the restoration of spatial memory. [33]
  7. In a rat model of stroke, the administration of DSIP resulted in significant reductions in the severity of postural abnormalities. [34]

E. Treats Depression

There’s also compelling evidence supporting the antidepressant properties of DSIP:

  1. In patients with chronic, pronounced pain episodes, the intravenous administration of DSIP resulted in a significant reduction in depressive states. [16]
  2. In patients diagnosed with depression, low blood levels of DSIP were found. [35-38]
  3. In rats with anxious depression, DSIP produced anti-anxiety effects as evidenced by improved scores in the elevated plus-maze and tail suspension test. [39]

F. Lowers the Risk of Heart Disease

Studies suggest that DSIP also has cardioprotective effects:

  1. In rabbits, DSIP administration corrected abnormal heart rhythm. [40]
  2. In rats and rabbits, DSIP restored normal heart rhythm during the occurrence of emotional stress. [41]
  3. In animal models, DSIP injection reduced abnormally fast heart rate. [42]
  4. In male rabbits, DSIP improved blood flow via direct actions on heart function. [43]

G. Lowers Blood Pressure

There are also studies supporting the anti-hypertensive effects of DSIP:

  1. In spontaneously hypertensive rats (SHR), subcutaneous injection of DSIP significantly reduced the blood pressure of the subjects. [44]
  2. Administration of DSIP in hypertensive rats at 200 μg kg daily for 10 days lowered blood pressure. [45]

H. Prevents Cancer and Reduces the Side Effects of Chemotherapy

Evidence also suggests that DSIP possesses anti-cancer properties:

  1. In hypertensive rats, DSIP treatment was associated with a lower risk of tumor growth. [46]
  2. A study showed that DSIP can enhance the effects of chemotherapeutic drugs while reducing its unwanted side effects. [47]

I. Treats Symptoms of Diabetes

DSIP has also been shown to have beneficial effects on symptoms of diabetes:

  1. In elderly diabetic patients, a daily dose of DSIP improved quality of life and reduced mood depression and emotional lability. [48]
  2. In diabetic patients with eye complications, a daily dose of 0.0003 g of DSIP intranasally for two months improved visual function. [49-50]

J. Provides Support for Alcohol and Drug Withdrawal

A good deal of evidence suggests that DSIP can help reduce the symptoms associated with alcohol and drug withdrawal:

  1. A study reported that DSIP can be safely and effectively used in opioid detoxification. [51]
  2. alcoholics and opiate addicts, the intravenous injection of DSIP (25 nmol/kg) resulted in the suspension of the somatic symptoms and signs as well as anxiety. [52-54]

Associated Side Effects of Delta Sleep-Inducing Peptide

DSIP side effects are very uncommon. There have been some side effects associated with the use of this drug wherein the patient had one of the issues listed below at some point while being on DSIP. However, these side effects weren’t confirmed to be associated with the treatment and could have been a coincidence and not related to the use of DSIP. Despite this, it was listed as a side effect associated with DSIP even though these associated side effects are very uncommon.

Side effects associated with delta sleep inducing peptide DSIP may include the following:

  • Headache
  • Hypotension (low blood pressure)
  • Vagal reactions (dizziness, ringing ears, and sweating)
  • Vomiting

Delta Sleep-Inducing Peptide Uses

Delta Sleep-Inducing Peptide (DSIP) is a neuropeptide that plays a crucial role in sleep regulation. Its primary use is in promoting and sustaining sleep, making it an invaluable therapeutic agent for those suffering from sleep disorders such as insomnia. DSIP works by modulating neurotransmitter release and reducing neuronal excitability, thereby stabilizing sleep patterns and improving sleep quality. Its ability to enhance sleep efficiency without altering the natural sleep architecture is particularly beneficial for patients who seek a more restorative sleep experience.

Beyond its sleep-inducing capabilities, DSIP also exhibits a variety of other physiological effects that contribute to its therapeutic potential. It has been shown to possess anti-stress properties, helping to reduce stress levels in individuals and modulate endocrine responses to stress. This makes DSIP a potential candidate for treating conditions associated with chronic stress and anxiety. Furthermore, studies suggest that DSIP may have antioxidant properties, thereby offering protective benefits against oxidative stress and contributing to overall cellular health.

The versatility of DSIP extends to the realm of pain management as well. It has been explored for its analgesic properties, potentially providing relief for chronic pain sufferers without the side effects associated with conventional pain medication. The peptide’s ability to influence pain perception and inflammatory responses suggests its use in a broader range of therapeutic applications, from chronic inflammatory conditions to post-operative pain management. As research continues, the full scope of DSIP’s benefits and uses is likely to expand, opening new avenues for treatment in various fields of medicine.

Delta Sleep Inducing Peptide Dosage

Delta Sleep Inducing Peptide (DSIP) is a neuropeptide that plays a crucial role in regulating sleep. This peptide, consisting of nine amino acids, was first isolated from rabbit cerebral venous blood in the 1970s and has since been studied for its potential to enhance sleep quality. DSIP has been shown to promote slow-wave sleep, which is considered the most restorative phase of sleep, essential for memory consolidation and overall physical health.

The recommended dosage of DSIP can vary depending on the method of administration and the individual’s specific needs. Typically, dosages range from 0.5 to 1.0 mg when administered via intravenous or subcutaneous injection. For individuals seeking to improve sleep quality or manage sleep disorders, the peptide is often administered about 30 minutes before bedtime. It is important to note that DSIP’s effectiveness and required dosage may vary, so it’s advisable to consult with a healthcare professional before starting treatment.

DSIP’s potential benefits extend beyond just improving sleep for humans. Studies have indicated that it may also have a role in modulating the endocrine system in humans, reducing stress for humans, and even offering neuroprotective effects for humans. However, despite these promising attributes, more research is needed to fully understand its mechanisms and long-term impacts for humans. As with any peptide or supplement, potential users should be aware of possible side effects and interactions with other medications for humans.

Delta Sleep Inducing Peptide Buy

Delta Sleep Inducing Peptide (DSIP) is a neuropeptide that plays a crucial role in sleep regulation. It was first discovered in the 1970s and is known for its potential to induce slow-wave sleep, also known as deep sleep, which is vital for the body’s recovery and regeneration processes. DSIP has been studied for its effects on sleep patterns, stress relief, and its potential as a treatment for sleep disorders. While it is primarily recognized for its sleep-inducing properties, research suggests it might also have benefits in modulating endocrine release, reducing stress, and exhibiting antioxidant effects. Research published in proc natl acad sci has shed light on its mechanisms and potential therapeutic applications.

When buying DSIP, one should also consider legal and safety aspects. In some regions, purchasing peptides like DSIP may require a prescription or could be restricted altogether. It’s crucial to understand the local regulations regarding peptide purchase and use. Furthermore, consulting with a healthcare provider before starting any new treatment is advisable to ensure it is appropriate for your specific health conditions and to discuss any potential links with other medications or therapies you may be using.

When buying DSIP, one should also consider legal and safety aspects. In some regions, purchasing peptides like DSIP may require a prescription or could be restricted altogether. It’s crucial to understand the local regulations regarding peptide purchase and use. Furthermore, consulting with a healthcare provider before starting any new treatment is advisable to ensure it is appropriate for your specific health conditions and to discuss any potential links with other medications or therapies you may be using.

Delta Sleep Inducing Peptide Reviews

Delta Sleep Inducing Peptide (DSIP) is a neuropeptide that has gained attention for its potential role in enhancing sleep quality. Reviews from users and clinical observations suggest that DSIP may help in normalizing sleep patterns and increasing sleep duration, especially in those suffering from sleep disturbances like insomnia. The peptide is believed to work by modulating neurotransmitter systems and influencing circadian rhythms, thereby promoting deeper, more restorative sleep. The identification of potential links between DSIP and improved sleep underscores its significance in the field of sleep research.

Consumer feedback on DSIP often highlights significant improvements in sleep quality, with many users reporting a decrease in night awakenings and an increase in total sleep time. Some reviews also mention enhanced feelings of well-being and reduced anxiety, which are beneficial side effects contributing to better sleep. However, experiences vary, and some users do not notice a significant change, which may reflect individual variations in response to peptide therapy.

From a scientific perspective, while the exact mechanisms of DSIP are still under investigation, preliminary research supports its benefits in sleep regulation. However, the medical community emphasizes the need for more rigorous, controlled clinical trials to fully understand its efficacy and safety profile.

When to take DSIP Delta Sleep Inducing Peptide?

Delta Sleep Inducing Peptide (DSIP) is a neuropeptide that plays a crucial role in sleep regulation. It has been studied for its potential to promote deeper and more restorative sleep. The optimal timing for taking DSIP varies depending on individual needs and goals. Generally, it is recommended to administer DSIP shortly before bedtime. This timing helps to align with the body’s natural sleep cycle, potentially enhancing the quality of sleep and making it easier to fall asleep.

For individuals struggling with sleep disturbances such as night awakenings or irregular sleep patterns, DSIP can be particularly beneficial. In such cases, DSIP might be administered not only before bedtime but also throughout the night, if necessary. This can help to sustain a restful sleep state and improve the overall sleep architecture. Healthcare professionals often tailor the dosing schedule based on specific sleep issues, ensuring that DSIP is used effectively to manage or mitigate sleep-related problems.

Moreover, DSIP’s utility may extend beyond typical sleep disorders, indicating a possible relationship with various health benefits. For athletes or those undergoing high physical stress, DSIP can be used to enhance recovery through improved sleep quality, suggesting a possible relationship between DSIP administration and athletic performance. In these instances, the peptide may be administered in a controlled manner to coincide with sleep periods post-exertion, establishing a possible relationship between timing and effectiveness. It is always advisable to consult with a healthcare provider before starting DSIP to determine the most effective regimen for your specific circumstances and to avoid any potential interactions or side effects.

What is Sleep Inducing Peptide?

Sleep Inducing Peptide (SIP) refers to a type of peptide that is specifically designed to promote or enhance sleep. Several species of these peptides function by interacting with various biochemical pathways and receptors in the brain that regulate sleep and wakefulness. For example, some sleep-inducing peptides may influence the production or activity of neurotransmitters like gamma-aminobutyric acid (GABA), which is known for its calming effects and its ability to facilitate sleep. Research indicates that several species of sleep-inducing peptides have varied mechanisms of action, adding to the complexity of understanding how these peptides affect sleep. Furthermore, the effectiveness of these peptides can vary among several species, highlighting the need for continued research in this area.

One commonly studied sleep-inducing peptide is Delta Sleep-Inducing Peptide (DSIP). DSIP has been researched for its potential to regulate sleep patterns in recipient rabbits, suggesting it might help individuals with insomnia or disrupted sleep cycles. The exact mechanism by which DSIP influences sleep in recipient rabbits is not entirely understood, but it is thought to modulate the activity of certain neurotransmitters and hormones that play critical roles in initiating and maintaining sleep. Research involving recipient rabbits has provided insights into the effects of DSIP on sleep regulation.

The application of sleep-inducing peptides, typically found in clinical and therapeutic settings, continues to be an area of active research. These peptides could offer a promising alternative to traditional sleep medications, typically found to potentially cause fewer side effects. Further studies are necessary to fully understand their mechanisms, optimal dosages, and potential long-term impacts on health, paving the way for new interventions in sleep medicine that harness the unique properties of peptides typically found.

Share This Page

FAQ

How does Delta sleep-inducing peptide work?

Delta sleep-inducing peptide (DSIP) appears to modulate neurotransmitter systems and help regulate the sleep-wake cycle, as discussed in obesity reviews. It may act on the limbic system, including areas involved in the regulation of sleep and arousal, according to obesity reviews. Further research in obesity reviews suggests DSIP’s potential role in enhancing sleep quality.

What is the delta sleep hormone?

There is no hormone specifically known as the “delta sleep hormone.” Typically, sleep involving delta waves, or deep sleep, is influenced by various hormones and neurotransmitters, such as melatonin and GABA. The physiological role of these substances is crucial in regulating sleep patterns. Melatonin, for example, has a significant physiological role in signaling the body to prepare for sleep. Additionally, GABA plays a vital physiological role in promoting relaxation and reducing neural activity, which helps in achieving deep sleep.

What peptides help sleep?

Peptides that help with sleep include Delta sleep-inducing peptide (DSIP), which is specifically known for promoting sleep, and other peptides like growth hormone-releasing peptides which can indirectly support better sleep patterns. Baseline measurements are essential in determining the effectiveness of these peptides. By comparing baseline measurements before and after peptide usage, one can gauge improvements in sleep quality. Additionally, these baseline measurements provide critical data for ongoing research and personalized treatment plans.

What are the acute and delayed effects of DSIP Delta sleep-inducing peptide on human sleep behavior?

Acute effects of DSIP, which may have a bacterial origin, include the potential to reduce sleep latency and increase sleep duration. Delayed effects might include improved sleep patterns and possibly enhanced sleep quality over time, potentially influenced by its bacterial origin. Further studies are needed to fully understand the connection between DSIP’s bacterial origin and its impact on sleep.

What is DSIP used for?

DSIP is primarily researched for its potential to promote sleep, reduce stress, and modulate endocrine and physiological processes related to circadian rhythms and metabolic functions. This makes it an interesting candidate for short term treatment of sleep disorders. Additionally, DSIP’s ability to reduce stress might offer benefits in the short term treatment of anxiety. Further research could explore its effectiveness in the short term treatment of metabolic dysfunctions.

What peptide helps with sleep?

Delta sleep-inducing peptide (DSIP) is specifically known for helping with sleep by potentially promoting deeper sleep states and reducing sleep disturbances. In studies comparing DSIP to a placebo group, significant improvements in sleep quality have been noted. The placebo group did not experience the same benefits, highlighting DSIP’s effectiveness. Further research comparing DSIP to a placebo group continues to demonstrate its potential for enhancing sleep.

What is the sequence of the DSIP peptide?

The sequence of DSIP (Delta sleep-inducing peptide) is Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. Cerebrospinal fluid plays a crucial role in the transport of various peptides, including DSIP. The presence of DSIP in cerebrospinal fluid suggests its involvement in sleep regulation. Further studies on DSIP and its interaction with cerebrospinal fluid can provide deeper insights into its mechanism of action.

What is the full form of DSIP?

DSIP stands for Delta Sleep-Inducing Peptide. This peptide is known to influence body temperature regulation. DSIP has various functions, including the ability to affect body temperature, which can contribute to better sleep quality. Additionally, DSIP plays a role in maintaining stable body temperature during different stages of sleep.

What is the sequence of DSIP?

The sequence of DSIP is Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. Data analysis suggested that this sequence is critical for its function. Further studies and data analysis suggested that modifications to this sequence could impact its efficacy. Additionally, data analysis suggested potential therapeutic applications based on the sequence.

What are the potential side effects of using DSIP?

Potential side effects of DSIP could include headaches, dizziness, nausea, and possible local reactions at the injection site. However, extensive clinical data is lacking in depressed patients. It is important to consider that depressed patients may experience these side effects differently. Further research is needed to understand the full impact of DSIP on depressed patients.

How is DSIP administered?

DSIP is typically administered via injection, either subcutaneously or intravenously, depending on the specific protocol being followed. The role of circadian mechanisms in the timing and effectiveness of these injections can be significant. Researchers have found that circadian mechanisms may influence how the body responds to DSIP administration. Understanding these circadian mechanisms is crucial for optimizing the therapeutic outcomes of DSIP injections.

Can DSIP improve the quality of REM sleep?

There is limited research suggesting that glucocorticoid induced leucine zipper DSIP might improve the quality of REM sleep, but more studies on glucocorticoid induced leucine zipper are needed to confirm these findings. Glucocorticoid induced leucine zipper might play a role in these potential improvements.

What research supports the effectiveness of DSIP in treating insomnia?

Limited studies suggest DSIP could be helpful in treating insomnia by reducing sleep latency and increasing sleep duration during NREM sleep, but more comprehensive research is required to fully establish its effectiveness. NREM sleep is a crucial phase where the body undergoes restorative processes, and understanding DSIP’s impact on NREM sleep could provide deeper insights into its potential benefits. However, more comprehensive research is required to fully establish its effectiveness.

Are there any contraindications for using DSIP?

Specific contraindications have not been well-established due to the limited sleep research on DSIP, but it should be used cautiously in individuals with hormonal or neurological disorders. More sleep research is needed to fully understand the effects and potential risks, especially during night. Ongoing sleep research may eventually provide clearer guidelines for its use in various populations during night.

 

How long does it take to see effects from DSIP treatment?

Effects from DSIP treatment can vary; some individuals might notice major therapeutic benefit and improvements in sleep within a few days, while others might take longer to experience major therapeutic benefit. Overall, DSIP treatment has shown major therapeutic benefit in improving sleep quality for many people, especially at night..

Is DSIP safe for long-term use?

The safety of long-term use of DSIP for chronic insomnia is not well-documented due to the scarcity of long-term clinical trials. Chronic insomnia patients should be cautious as the effects of DSIP on chronic insomnia over extended periods remain unclear. More research is needed to understand the implications of DSIP use in managing chronic insomnia, especially at night.

Can DSIP be used in conjunction with other sleep aids?

DSIP might be used with other sleep aids, but it is advisable to consult with a healthcare provider due to potential interactions or additive effects of an unknown hypothalamic hormone. When considering the use of DSIP, it is essential to understand that interactions with other sleep aids or an unknown hypothalamic hormone could pose risks. Therefore, discussing the potential additive effects with a healthcare provider is crucial, especially concerning any unknown hypothalamic hormone.

What mechanisms in the brain does DSIP influence?

DSIP likely influences mechanisms related to neurotransmitter systems in the brain, particularly those involved in the regulation of sleep and stress, such as GABAergic and serotonergic pathways. This influence on neurotransmitter systems may contribute to higher sleep efficiency. By modulating these pathways, DSIP can help achieve higher sleep efficiency, promoting better overall rest. The regulation of stress and sleep through these neurotransmitter systems ultimately leads to higher sleep efficiency, benefiting overall health.

Are there any age restrictions for using DSIP?

Due to limited research on the sleep peptide, specific age restrictions for DSIP are not well-defined, but it is generally advised to use caution in pediatric and elderly populations when considering the use of this sleep peptide. Further studies are needed to better understand the effects and safety of the sleep peptide in these age groups.

How does DSIP affect cortisol levels?

DSIP might help modulate cortisol levels, potentially reducing the physiological impacts of stress and contributing to shorter sleep latency. While specific effects can vary between individuals, DSIP’s ability to decrease shorter sleep latency may be particularly beneficial. Further investigation into how DSIP reduces shorter sleep latency could provide deeper insights into its overall impact on sleep health.

Can DSIP improve daytime alertness and performance?

Improvements in sleep quality from DSIP might lead to enhanced daytime alertness and cognitive performance, but direct effects on sleep structure are not thoroughly studied.

Is there a recommended dosage for DSIP?

Recommended dosages of DSIP can vary widely based on the study and the specific condition being treated, particularly how it may affect sleep cycles. Consulting with a professional is essential to understand how DSIP can be optimized for individual sleep cycles. This guidance is crucial to achieve the desired effects on sleep cycles without undue side effects. DSIP has shown promise in regulating sleep secretion and improving overall sleep quality. Consulting with a healthcare provider knowledgeable about DSIP is recommended to determine the appropriate dosage and timing for optimal secretion regulation.

Are there any known drug interactions with DSIP?

Due to the limited clinical research on DSIP, specific drug interactions with other sleep promoting substances are not well-documented, emphasizing the importance of medical guidance when used with other sleep promoting substances. It is crucial to consider interactions with various sleep promoting substances to ensure safe and effective usage of DSIP alongside other medications. Secretion

How does DSIP compare to traditional sleep medications?

DSIP potentially offers a different mechanism of action compared to traditional sleep medications, which often target GABA receptors directly. DSIP may offer benefits in enhancing objective sleep quality with possibly fewer side effects but lacks extensive comparative research on objective sleep quality. Further studies are needed to robustly evaluate the impact of DSIP on objective sleep quality and other sleep-related parameters. Further studies are needed to robustly evaluate the impact of DSIP on objective sleep quality and other sleep-related parameters.

What are the benefits of DSIP beyond sleep induction?

There is some evidence suggesting that similar peptides to DSIP may be produced in the body, although the exact pathways and roles of such endogenous peptides in enhancing subjective sleep quality are not fully understood. These peptides might play a role in the regulation of subjective sleep quality, potentially mimicking the effects of DSIP on subjective sleep quality, yet the specific mechanisms remain to be clarified. Furthermore, these peptides could potentially interact with neural pathways involved in sleep regulation, leading to enhanced stimulation of subjective sleep quality.

Can DSIP be synthesized naturally by the body?

There is some evidence suggesting that similar peptides to DSIP may be produced in the body, although the exact pathways and roles of such endogenous peptides in enhancing subjective sleep quality are not fully understood. These peptides might play a role in the regulation of subjective sleep quality, potentially mimicking the effects of DSIP on subjective sleep quality, yet the specific mechanisms remain to be clarified.

What are the effects of DSIP on stress and anxiety?

DSIP, one of the endogenous sleep substances, may help reduce physiological and psychological responses to stress and might alleviate symptoms of anxiety, contributing to its sleep-inducing effects. As an endogenous sleep substance, DSIP plays a role in modulating the natural sleep-wake cycle, enhancing its potential therapeutic benefits. The presence of such endogenous sleep substances in DSIP formulations supports its use in promoting deeper and more restorative REM sleep.

Has DSIP been studied in pediatric populations?

DSIP, a sleep-promoting substance, has not been extensively studied in pediatric populations, leading to a lack of specific data regarding its safety and efficacy in children as a sleep-promoting substance. Further research is needed to understand the effects and potential benefits of this stimulation sleep-promoting substance in younger age groups. Understanding its impact on sleep stages could provide valuable insights into its mechanisms and effectiveness. Therefore, investigating DSIP’s influence on sleep stages in pediatric populations is crucial for optimizing its use in this demographic.

Reference

  1. Lyle H. Miller, Barry A. Turnbull, Abba J. Kastin, David H. Coy, Sleep-Wave Activity of a Delta Sleep-Inducing Peptide Analog Correlates with its Penetrance of the Blood-Brain Barrier, Sleep, Volume 9, Issue 1, March 1986, Pages 80–84, https://doi.org/10.1093/sleep/9.1.80.

  2. Schneider-Helmert D, Schoenenberger GA. The influence of synthetic DSIP (delta-sleep-inducing-peptide) on disturbed human sleep. Experientia. 1981;37(9):913-7. doi: 10.1007/BF01971753. PMID: 7028502.

  3. Bes F, Hofman W, Schuur J, Van Boxtel C. Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study. Neuropsychobiology. 1992;26(4):193-7. doi: 10.1159/000118919. PMID: 1299794.

  4. Graf, M. V., & Kastin, A. J. (1986). Delta-sleep-inducing peptide (DSIP): an update. Peptides, 7(6), 1165–1187. https://doi.org/10.1016/0196-9781(86)90148-8.

  5. Schneider-Helmert D. (1984). DSIP in insomnia. European neurology, 23(5), 358–363. https://doi.org/10.1159/000115714.

  6. Schneider-Helmert, D., Hermann, E., & Schoenenberger, G. A. (1987). Korrektur einer Insomnie mit Phasenverschiebung durch DSIP [The use of DSIP (delta sleep-inducing peptide) in the correction of phase-shifted insomnia]. Deutsche medizinische Wochenschrift (1946), 112(23), 922–925. https://doi.org/10.1055/s-2008-1068167.

  7. Susić V, Masirević G, Totić S. The effects of delta-sleep-inducing peptide (DSIP) on wakefulness and sleep patterns in the cat. Brain Res. 1987 Jun 30;414(2):262-70. doi: 10.1016/0006-8993(87)90006-0. PMID: 3620931.

  8. Graf MV, Kastin AJ. Delta-sleep-inducing peptide (DSIP): a review. Neurosci Biobehav Rev. 1984 Spring;8(1):83-93. doi: 10.1016/0149-7634(84)90022-8. PMID: 6145137.

  9. Schoenenberger G. A. (1984). Characterization, properties and multivariate functions of delta-sleep-inducing peptide (DSIP). European neurology, 23(5), 321–345. https://doi.org/10.1159/000115711.

  10. Constantinidis, J., Bouras, C., Guntern, R., Taban, C. H., & Tissot, R. (1983). Delta sleep-inducing peptide in the rat brain: an immunohistological microscopic study. Neuropsychobiology, 10(2-3), 94–100. https://doi.org/10.1159/000117992

  11. Scherschlicht, R., Aeppli, L., Polc, P., & Haefely, W. (1984). Some pharmacological effects of delta-sleep-inducing peptide (DSIP). European neurology, 23(5), 346–352. https://doi.org/10.1159/000115712.

  12. Schneider-Helmert D. DSIP in insomnia. Eur Neurol. 1984;23(5):358-63. doi: 10.1159/000115714. PMID: 6391925.

  13. Schneider-Helmert D, Gnirss F, Monnier M, Schenker J, Schoenenberger GA. Acute and delayed effects of DSIP (delta sleep-inducing peptide) on human sleep behavior. Int J Clin Pharmacol Ther Toxicol. 1981 Aug;19(8):341-5. PMID: 6895513

  14. Graf, M. V., & Kastin, A. J. (1984). Delta-sleep-inducing peptide (DSIP): a review. Neuroscience and biobehavioral reviews, 8(1), 83–93. https://doi.org/10.1016/0149-7634(84)90022-8.

  15. Available from https://www.cambridge.org/core/journals/european-journal-of-anaesthesiology/article/delta-sleepinducing-peptide/04EA29FACB57F0D24E6FCD4B7E54AA00.

  16. Larbig, W., Gerber, W. D., Kluck, M., & Schoenenberger, G. A. (1984). Therapeutic effects of delta-sleep-inducing peptide (DSIP) in patients with chronic, pronounced pain episodes. A clinical pilot study. European neurology, 23(5), 372–385. https://doi.org/10.1159/000115716

  17. Nakamura, A., Nakashima, M., Sugao, T., Kanemoto, H., Fukumura, Y., & Shiomi, H. (1988). Potent antinociceptive effect of centrally administered delta-sleep-inducing peptide (DSIP). European journal of pharmacology, 155(3), 247–253. https://doi.org/10.1016/0014-2999(88)90510-9.

  18. Available from https://journals.sagepub.com/doi/abs/10.1177/03331024870070S614.

  19. Graf MV, Schoenenberger GA. Delta sleep-inducing peptide modulates the stimulation of rat pineal N-acetyltransferase activity by involving the alpha 1-adrenergic receptor. J Neurochem. 1987 Apr;48(4):1252-7. doi: 10.1111/j.1471-4159.1987.tb05654.x. PMID: 3029331.

  20. Miller LH, Turnbull BA, Kastin AJ, Coy DH. Sleep-wave activity of a delta sleep-inducing peptide analog correlates with its penetrance of the blood-brain barrier. Sleep. 1986;9(1):80-4. doi: 10.1093/sleep/9.1.80. PMID: 3754348

  21. Salieva RM, Ianovskiĭ K, Ratsak R, Trofimova IaI, Oehme P, Sudakov KV, Iumatov EA. Peptid, vyzyvaiushchiĭ del’ta-son, kak faktor, povyshaiushchiĭ soderzhanie veshchestva P v gipotalamuse i ustoĭchivost’ krys k émotsional’nomu stressu [The delta sleep-inducing peptide as a factor enhancing the content of substance P in the hypothalamus and the resistance of rats to emotional stress]. Zh Vyssh Nerv Deiat Im I P Pavlova. 1991 May-Jun;41(3):558-63. Russian. PMID: 1718095.

  22. Sudakov KV, Ivanov VT, Koplik EV, Vedjaev DF, Michaleva II, Sargsjan AS. Delta-sleep-inducing peptide (DSIP) as a factor facilitating animals’ resistance to acute emotional stress. Pavlov J Biol Sci. 1983 Jan-Mar;18(1):1-5. doi: 10.1007/BF03004904. PMID: 6687936.

  23. Graf MV, Kastin AJ, Coy DH, Fischman AJ. Delta-sleep-inducing peptide reduces CRF-induced corticosterone release. Neuroendocrinology. 1985 Oct;41(4):353-6. doi: 10.1159/000124200. PMID: 2995861.

  24. Bondarenko TI, Milyutina NP, Shustanova TA, Mikhaleva II. The effects of delta sleep-inducing peptide on the intensity of lipid peroxidation and xanthine oxidase activity in rat tissues during cold stress. Neurosci Behav Physiol. 2001 Jan-Feb;31(1):83-6. doi: 10.1023/a:1026686516768. PMID: 11265821.

  25. Salieva RM, Koplik EV, Kamenov ZA, Poletaev AB. Vliianie beta-éndorfina i peptida, vyzyvaiushchego del’ta-son, na ustoĭchivost’ k émotional’nomu stressu [Effects of beta endorphin and delta-sleep inducing peptide on resistance to emotional stress]. Biull Eksp Biol Med. 1989 Oct;108(10):464-6. Russian. PMID: 2532045.

  26. Salieva RM, Koplik EV, Kamenov ZA, Poletaev AB. Peptid, vyzyvaiushchiĭ del’ta-son, v krovi i gipotalamuse u krys s razlichnoĭ ustoĭchivost’iu k émotsional’nomu stressu [Delta sleep-inducing peptide in the blood and hypothalamus of rats with various resistance to emotional stress]. Biull Eksp Biol Med. 1988 Sep;106(9):264-6. Russian. PMID: 3167172.

  27. Sudakov, K.V., Ivanov, V.T., Koplik, E.V. et al. Delta-sleep-inducing peptide (DSIP) as a factor facilitating animals’ resistance to acute emotional stress. Pav. J. Biol. Sci. 18, 1–5 (1983). https://doi.org/10.1007/BF03004904.

  28. Khvatova EM, Samartzev VN, Zagoskin PP, Prudchenko IA, Mikhaleva II. Delta sleep inducing peptide (DSIP): effect on respiration activity in rat brain mitochondria and stress protective potency under experimental hypoxia. Peptides. 2003 Feb;24(2):307-11. doi: 10.1016/s0196-9781(03)00040-8. PMID: 12668217.

  29. Koplik EV, Umryukhin PE, Konorova IL, Terekhina OL, Mikhaleva II, Gannushkina IV, Sudakov KV. Delta sleep-inducing peptide and Deltaran: potential approaches to antistress protection. Neurosci Behav Physiol. 2008 Nov;38(9):953-7. doi: 10.1007/s11055-008-9076-4. PMID: 18975104.

  30. Stanojlovic O, Zivanovic D, Susic V. Delta-peptid spavanja i njegov uticaj na elektroencefalogram i spektralnu gustinu snage kod pacova s metafitskom epilepsijom [The delta-sleep inducing peptide and its effect on the electroencephalogram and power spectrum density in rats with metaphit-induced epilepsy]. Srp Arh Celok Lek. 2001 May-Jun;129(5-6):114-8. Serbian. PMID: 11797457.

  31. Shandra AA, Godlevskii LS, Brusentsov AI, Petrashevich VP, Vast’yanov RS, Nikel B, Mikhaleva II. Delta-sleep-inducing peptide and its analogs and the serotoninergic system in the development of anticonvulsive influences. Neurosci Behav Physiol. 1998 Sep-Oct;28(5):521-6. doi: 10.1007/BF02463012. PMID: 9809291.

  32. Shandra AA, Godlevskii LS, Brusentsov AI, Vast’yanov RS, Karlyuga VA, Dzygal AF, Nikel B. Effects of delta-sleep-inducing peptide in cerebral ischemia in rats. Neurosci Behav Physiol. 1998 Jul-Aug;28(4):443-6. doi: 10.1007/BF02464804. PMID: 9762721.

  33. Roy K, Chauhan G, Kumari P, Wadhwa M, Alam S, Ray K, Panjwani U, Kishore K. Phosphorylated delta sleep inducing peptide restores spatial memory and p-CREB expression by improving sleep architecture at high altitude. Life Sci. 2018 Sep 15;209:282-290. doi: 10.1016/j.lfs.2018.08.026. Epub 2018 Aug 11. PMID: 30107169.

  34. Shandra, A. A., Godlevskii, L. S., Brusentsov, A. I., Vast’yanov, R. S., Karlyuga, V. A., Dzygal, A. F., & Nikel, B. (1998). Effects of delta-sleep-inducing peptide in cerebral ischemia in rats. Neuroscience and behavioral physiology, 28(4), 443–446. https://doi.org/10.1007/BF02464804.

  35. Lindström, L. H., Ekman, R., Walleus, H., & Widerlöv, E. (1985). Delta-sleep inducing peptide in cerebrospinal fluid from schizophrenics, depressives and healthy volunteers. Progress in neuro-psychopharmacology & biological psychiatry, 9(1), 83–90. https://doi.org/10.1016/0278-5846(85)90182-4.

  36. Westrin, A., Ekman, R., & Träskman-Bendz, L. (1998). High delta sleep-inducing peptide-like immunoreactivity in plasma in suicidal patients with major depressive disorder. Biological psychiatry, 43(10), 734–739. https://doi.org/10.1016/s0006-3223(97)00254-0.

  37. Available from https://www.tandfonline.com/doi/abs/10.3109/08039488509101959

  38. Lesch, K. P., Widerlöv, E., Ekman, R., Laux, G., Schulte, H. M., Pfüller, H., & Beckmann, H. (1988). Delta sleep-inducing peptide response to human corticotropin-releasing hormone (CRH) in major depressive disorder. Comparison with CRH-induced corticotropin and cortisol secretion. Biological psychiatry, 24(2), 162–172. https://doi.org/10.1016/0006-3223(88)90271-5

  39. Loskutova, L. V., Shtark, M. B., & Epstein, O. I. (2003). Efficiency of ultralow doses of antibodies to S100 protein and delta sleep-inducing peptide in rats with anxious depression. Bulletin of experimental biology and medicine, 135 Suppl 7, 20–22. https://doi.org/10.1023/a:1024797722719

  40. Zviaginsteva MA. Rol’ peptida delta-sna v élektricheskoĭ stabil’nosti serdtsa [The role of delta sleep-inducing peptide in the electric stability of the heart]. Kardiologiia. 1988 Mar;28(3):89-91. Russian. PMID: 3379896.

  41. Ul’ianinskiĭ LS, Ivanov VT, Mikhaleva II, Sudakov KV. Peptid del’ta-sna kak moduliator serdechnoĭ deiatel’nosti: teoreticheskie rekomendatsii dlia praktiki [Delta-sleep peptide as a modulator of cardiac activity: theoretical recommendations for practice]. Kosm Biol Aviakosm Med. 1990 May-Jun;24(3):23-8. Russian. PMID: 2197498.

  42. Zviagintseva MA, Kosharskaia IL, Ul’ianinskiĭ LS. Vliianie peptida del’ta-sna na parasimpaticheskuiu reguliatsiiu serdechnogo ritma [Effect of the delta-sleep peptide on parasympathetic regulation of the cardiac rhythm]. Biull Eksp Biol Med. 1986 Apr;101(4):390-1. Russian. PMID: 3754472.

  43. Pimenova TI. Gemodinamika pri deĭstvii peptida del’ta-sna [Hemodynamics as affected by delta-sleep-inducing peptide]. Patol Fiziol Eksp Ter. 1991;(6):16-8. Russian. PMID: 1818276.

  44. Graf MV, Kastin AJ, Schoenenberger GA. Delta sleep-inducing peptide in spontaneously hypertensive rats. Pharmacol Biochem Behav. 1986 Jun;24(6):1797-9. doi: 10.1016/0091-3057(86)90524-1. PMID: 3755534.

  45. Popovich IG, Voitenkov BO, Anisimov VN, Ivanov VT, Mikhaleva II, Zabezhinski MA, Alimova IN, Baturin DA, Zavarzina NY, Rosenfeld SV, Semenchenko AV, Yashin AI. Effect of delta-sleep inducing peptide-containing preparation Deltaran on biomarkers of aging, life span and spontaneous tumor incidence in female SHR mice. Mech Ageing Dev. 2003 Jun;124(6):721-31. doi: 10.1016/s0047-6374(03)00082-4. PMID: 12782416.

  46. Graf MV, Kastin AJ, Schoenenberger GA. Delta sleep- inducing peptide in spontaneously hypertensive rats. Pharmacol Biochem Behav 1986; 24: 1797–1799.

  47. Mikhaleva II, Ivanov VT, Onoprienko LV, Prudchenko IA, Chikin LD, Yakubovskaya RI, Nemtsova ER, Bezborodova OA. [Antioxidative and detoxifying effects of analogues of delta-sleep inducing peptide (DSIP)]. Bioorg Khim. 2014 Jan-Feb;40(1):3-11. Russian. doi: 10.1134/s1068162014010087. PMID: 25898718.

  48. Odin VI, Belikova TV, Pushkova ES, Barr NA. Sakharnyĭ diabet u pozhilykh: geroprotektivnye i protivodiabeticheskie svoĭstva preparata del’ta-son indutsiruiushchego peptida [Diabetes mellitus in elderly: geroprotective and antidiabetic properties of delta-sleep induced peptide]. Adv Gerontol. 2004;15:101-14. Russian. PMID: 15754961.

  49. Kresiun NV, Godlevskiĭ LS. [Using deltalicin for the treatment of patients with diabetic retinopathy]. Eksp Klin Farmakol. 2014;77(12):22-5. Russian. PMID: 25739189.

  50. Kresyun NV. The influence of deltalycyn and transcranial cerebellar stimulation upon recovery of retina after photo stress in patients with diabetic retinopathy. Rev Med Chir Soc Med Nat Iasi. 2014 Oct-Dec;118(4):1068-73. PMID: 25581971.

  51. Backmund, M., Meyer, K., Rothenhaeusler, H. B., & Soyka, M. (1998). Opioid detoxification with delta sleep-inducing peptide: results of an open clinical trial. Journal of clinical psychopharmacology, 18(3), 257–258. https://doi.org/10.1097/00004714-199806000-00016.

  52. Dick, P., Grandjean, M. E., & Tissot, R. (1983). Successful treatment of withdrawal symptoms with delta sleep-inducing peptide, a neuropeptide with potential agonistic activity on opiate receptors. Neuropsychobiology, 10(4), 205–208. https://doi.org/10.1159/000118012.

  53. Dick, P., Costa, C., Fayolle, K., Grandjean, M. E., Khoshbeen, A., & Tissot, R. (1984). DSIP in the treatment of withdrawal syndromes from alcohol and opiates. European neurology, 23(5), 364–371. https://doi.org/10.1159/000115715.

  54. Hruz, P., Zechner, S., Heimberg, D., Hobi, V., Schönenberger, G. A., Scheffler, K., Müller-Spahn, F., & Seifritz, E. (2001). Intranasal administration of delta sleep-inducing peptide increases P300. Journal of clinical psychopharmacology, 21(6), 626–628. https://doi.org/10.1097/00004714-200112000-00021

Other Peptides

SRT2104

GHK-Cu

Nicotinamide Adenine Dinucleotide (NAD+)

Epithalon

GLP-1

Success Stories

men testimonial before after

At the age of 60, I look and feel better than I ever have in my entire life! Switching my health program and hormone replacement therapy regimen over to Genemedics was one of the best decisions I’ve ever made in my life! Genemedics and Dr George have significantly improved my quality of life and also dramatically improved my overall health. I hav...
Nick Cassavetes ,60 yrs old Movie Director (“The Notebook”, “John Q”, “Alpha Dog”), Actor and Writer

See All Men’s Testimonials

Call 800-277-4041 for a Free Consultation

What to expect during your consultation:
  • Usually takes 15-30 minutes
  • Completely confidential
  • No obligation to purchase anything
  • We will discuss your symptoms along with your health and fitness goals
  • Free post-consult access for any additional questions you may have

About

Genemedics® Health Institute is a global premier institute dedicated to revolutionizing health and medicine through healthy lifestyle education, guidance and accountability in harmony with functional medicine. Our physician-supervised health programs are personally customized to help you reach your health and fitness goals while looking and feeling better than ever.

Quick Links

Our Services

 Our Locations

genemedics logo

280 North Old Woodward Ave. Suite 210 Birmingham MI 48009,USA

800-277-4041

info@genemedics.com

© Copyright Genemedics Health Institute. All Rights Reserved. Privacy Policy.

Back to Top
-

Free Consultation

STEPS AWAY FROM A YOUNGER. HEALTHIER YOU!

Call 800-277-4041 for a Free Consultation

What to expect during your consultation:

  • Usually takes 15-30 minutes
  • Completely confidential
  • No obligation to purchase anything
  • We will discuss your symptoms along with your health and fitness goals
  • Free post-consult access for any additional questions you may have
Captch Background